Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Annular ReduCtion for Transcatheter Treatment of Insufficient Mitral ValvE (ACTIVE): A Prospective, Multicenter, Randomized, Controlled Pivotal Trial to Assess Transcatheter Mitral Valve Repair With Edwards Cardioband System and GDMT vs GDMT Alone in Patients With FMR and Heart Failure

NCT03016975 is registered in ClinicalTrials.gov with Edwards Lifesciences as lead sponsor.

NCT NCT03016975
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03016975 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Annular ReduCtion for Transcatheter Treatment of Insufficient Mitral ValvE (ACTIVE): A Prospective, Multicenter, Randomized, Controlled Pivotal Trial to Assess Transcatheter Mitral Valve Repair With Edwards Cardioband System and GDMT vs GDMT Alone in Patients With FMR and Heart Failure
Lead sponsor
Edwards Lifesciences
Phase
Not applicable
Overall status
Terminated
Start date
June 1, 2017
Completion date
September 20, 2022
Enrollment
12 (actual)
Sites
24

Conditions

As the registry lists them; a condition with its own page is linked.

functional mitral regurgitation, mitral insufficiency, mitral regurgitation